Ratings by Raymond James (Steve Seedhouse)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/12/2026 | Viking Therapeutic | VKTX | Maintain | Strong Buy (N/A) |
|
Details | ||
| 9/19/2025 | 89bio Inc. | ETNB | Downgrade | Market Perform (Outperform) |
14.96 (14.84) |
-0.8% | Details | |
| 8/20/2025 | Viking Therapeutic | VKTX | Maintain | Strong Buy (N/A) |
|
Details | ||
| 8/19/2025 | Viking Therapeutic | VKTX | Maintain | Strong Buy (N/A) |
|
Details | ||
| 5/16/2024 | Viking Therapeutic | VKTX | Upgrade | Strong Buy (Outperform) |
78.01 (29.33) |
-62.4% | Details | |
| 2/27/2024 | Viking Therapeutic | VKTX | Maintain | Outperform (N/A) |
|
Details | ||
| 5/17/2023 | Viking Therapeutic | VKTX | Maintain | Outperform (N/A) |
|
Details | ||
| 3/29/2023 | Viking Therapeutic | VKTX | Maintain | Outperform (N/A) |
|
Details | ||
| 3/22/2023 | 89bio Inc. | ETNB | Maintain | Outperform (N/A) |
|
Details | ||
| 2/9/2023 | Viking Therapeutic | VKTX | Maintain | Outperform (N/A) |
|
Details | ||
| 12/19/2022 | Madrigal Pharmaceuticals | MDGL | Upgrade | Market Perform (Underperform) |
63.80 (488.15) |
665.13% | Details | |
| 10/27/2022 | Viking Therapeutic | VKTX | Maintain | Outperform (N/A) |
|
Details | ||
| 9/13/2022 | 89bio Inc. | ETNB | Maintain | Strong Buy (N/A) |
|
Details | ||
| 5/12/2022 | 89bio Inc. | ETNB | Upgrade | Strong Buy (Outperform) |
2.15 (14.96) |
595.81% | Details | |
| 7/29/2021 | Viking Therapeutic | VKTX | Maintain | Outperform (N/A) |
|
Details | ||
| 6/17/2021 | Viking Therapeutic | VKTX | Maintain | Outperform (N/A) |
|
Details | ||
| 5/25/2021 | Viking Therapeutic | VKTX | Downgrade | Outperform (Strong Buy) |
5.99 (78.01) |
1202.34% | Details | |
| 5/25/2021 | 89bio Inc. | ETNB | Downgrade | Outperform (Strong Buy) |
22.62 (14.84) |
-34.39% | Details | |
| 10/29/2020 | Viking Therapeutic | VKTX | Maintain | Strong Buy (N/A) |
|
Details | ||
| 5/1/2020 | Viking Therapeutic | VKTX | Maintain | Strong Buy (N/A) |
|
Details | ||
| 5/3/2019 | Viking Therapeutic | VKTX | Maintain | Strong Buy (N/A) |
|
Details | ||
| 4/15/2019 | Viking Therapeutic | VKTX | Maintain | Strong Buy (N/A) |
|
Details | ||
| 4/11/2019 | Viking Therapeutic | VKTX | Maintain | Strong Buy (Strong Buy) |
|
Details | ||
| 1/17/2019 | Viking Therapeutic | VKTX | Maintain | Strong Buy (N/A) |
|
Details | ||
| 11/19/2018 | Viking Therapeutic | VKTX | Upgrade | Strong Buy (Outperform) |
11.64 (29.33) |
151.98% | Details | |
| 11/19/2018 | Madrigal Pharmaceuticals | MDGL | Downgrade | Underperform (Market Perform) |
132.71 (63.80) |
-51.93% | Details |
